ClinicalTrials.Veeva

Menu

Cohort of Inflammatory Bowel Disease Patient in Yeouido St. Mary's Hospital

Y

Yeouido St. Mary's Hospital

Status

Completed

Conditions

Inflammatory Bowel Diseases

Study type

Observational

Funder types

Other

Identifiers

NCT05183256
SC20TISI0103

Details and patient eligibility

About

Pathologically Inflammatory bowel disease (IBD) is in chronic complex inflammatory gut pathological condition. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is considered a novel factor involved in the pathogenesis of IBD. The aim of this study is to analyze gut microbiota in IBD patients.

Full description

Inflammatory bowel disease (IBD) (Crohn's disease (CD) and ulcerative colitis (UC)) occurs worldwide with differences in epidemiology, etiology, and phenotype between regions. Pathologically Inflammatory bowel disease (IBD) is in chronic complex inflammatory gut pathological condition. Although the etiology of IBD is unknown, gut microbiota alteration (dysbiosis) is considered a novel factor involved in the pathogenesis of IBD. The DNA of microbiota will be investigated with samples of stool, colon tissue. The aim is to establish a cohort group for IBD (1), to make a database on cohort group characteristics such as endoscopic findings, disease severity, epidemiology, and prognosis (2), to analyze gut flora in IBD patients (3).

Enrollment

28 patients

Sex

All

Ages

Under 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The below 3 conditions must be met simultaneously.

    1. Patient who can voluntarily consent to this study.
    2. Patient who has inflammatory bowel disease.
    3. Patient who is aged less than 75 years.

Exclusion criteria

  • a patient meets any of the below conditions.

    1. If a patient has an IBD other than UC and CD.
    2. If a patient is vulnerable due to his/her position as an employee of Yeouido St.Mary's hospital or a medical student of the Catholic University of Korea.
    3. If a patient is pregnant.
    4. Foreign personal who cannot speak Korean.

Trial contacts and locations

1

Loading...

Central trial contact

Ilsoo Kim, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems